Free Trial

Eastman Chemical (EMN) Stock Forecast & Price Target

Eastman Chemical logo
$91.76 +1.73 (+1.92%)
(As of 12/20/2024 05:31 PM ET)

Eastman Chemical - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
7
Buy
6

Based on 13 Wall Street analysts who have issued ratings for Eastman Chemical in the last 12 months, the stock has a consensus rating of "Hold." Out of the 13 analysts, 7 have given a hold rating, and 6 have given a buy rating for EMN.

Consensus Price Target

$113.92
24.15% Upside
According to the 13 analysts' twelve-month price targets for Eastman Chemical, the average price target is $113.92. The highest price target for EMN is $128.00, while the lowest price target for EMN is $101.00. The average price target represents a forecasted upside of 24.15% from the current price of $91.76.
Get the Latest News and Ratings for EMN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Eastman Chemical and its competitors.

Sign Up

EMN Analyst Ratings Over Time

TypeCurrent Forecast
12/22/23 to 12/21/24
1 Month Ago
11/22/23 to 11/21/24
3 Months Ago
9/23/23 to 9/22/24
1 Year Ago
12/22/22 to 12/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
8 Buy rating(s)
6 Buy rating(s)
Hold
7 Hold rating(s)
8 Hold rating(s)
7 Hold rating(s)
10 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$113.92$111.50$108.07$90.69
Forecasted Upside24.15% Upside7.57% Upside1.35% Upside1.07% Upside
Consensus Rating
Hold
Hold
Moderate Buy
Hold

EMN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EMN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Eastman Chemical Stock vs. The Competition

TypeEastman ChemicalBasic Materials CompaniesS&P 500
Consensus Rating Score
2.46
2.76
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside24.15% Upside139.04% Upside14.54% Upside
News Sentiment Rating
Positive News

See Recent EMN News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/18/2024Citigroup
3 of 5 stars
P. Cunningham
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$118.00 ➝ $104.00+9.06%
11/26/2024Mizuho
3 of 5 stars
 Boost TargetNeutral ➝ Neutral$113.00 ➝ $117.00+11.77%
11/26/2024Wells Fargo & Company
3 of 5 stars
M. Sison
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$110.00 ➝ $125.00+18.09%
11/22/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingSector Perform ➝ Sector Perform$105.00 ➝ $105.00+0.12%
11/4/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$115.00 ➝ $110.00+9.06%
10/16/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$114.00 ➝ $119.00+7.87%
7/30/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral ➝ Neutral$105.00 ➝ $105.00+1.93%
7/29/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$103.00 ➝ $111.00+10.13%
5/23/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$106.00 ➝ $128.00+28.77%
4/29/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$102.00 ➝ $125.00+30.81%
4/9/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$101.00 ➝ $121.00+20.35%
2/15/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$110.00+33.95%
2/5/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$102.00 ➝ $101.00+22.26%
12/14/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$82.00 ➝ $92.00+5.54%
10/30/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$90.00+24.00%
7/31/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$115.00+32.37%
7/28/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$95.00 ➝ $98.00+11.81%
1/30/2023Vertical Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$94.00 ➝ $92.00+5.97%
1/30/2023Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Isaacson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeSector Outperform ➝ Sector Perform$100.00 ➝ $90.00+3.66%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:00 PM ET.


EMN Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Eastman Chemical is $113.92, with a high forecast of $128.00 and a low forecast of $101.00.

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Eastman Chemical in the last year. There are currently 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" EMN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EMN, but not buy additional shares or sell existing shares.

According to analysts, Eastman Chemical's stock has a predicted upside of 24.15% based on their 12-month stock forecasts.

Over the previous 90 days, Eastman Chemical's stock had 2 downgrades and 1 upgrade by analysts.

Eastman Chemical has been rated by research analysts at Bank of America, Citigroup, Deutsche Bank Aktiengesellschaft, Mizuho, Royal Bank of Canada, and Wells Fargo & Company in the past 90 days.

Analysts like Eastman Chemical less than other "basic materials" companies. The consensus rating for Eastman Chemical is Hold while the average consensus rating for "basic materials" companies is Moderate Buy. Learn more on how EMN compares to other companies.


This page (NYSE:EMN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners